| Dr Mark Albert Olson, PHARMD | |
|
915 W Marketview Dr, Champaign, IL 61822-1221 | |
| (217) 352-1987 | |
| (217) 352-2356 |
| Full Name | Dr Mark Albert Olson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 915 W Marketview Dr, Champaign, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144260381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051037559 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Albert Olson, PHARMD 915 W Marketview Dr, Champaign, IL 61822-1221 Ph: (217) 352-1987 | Dr Mark Albert Olson, PHARMD 915 W Marketview Dr, Champaign, IL 61822-1221 Ph: (217) 352-1987 |
News Archive
United Auto Workers will sell its 55% stake in the reorganized Chrysler as soon as possible to fund a trust that will cover retirees' health care costs, UAW President Ron Gettelfinger said Monday, the AP/Houston Chronicle reports.
Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.
OnCallData, whose pioneering electronic-prescribing product was the first electronic prescribing application to launch two-way connectivity with national pharmacy chains, announced this week that it has integrated its systems with ShareStream, a rich media platform that allows organizations to educate and train their workforces through multimedia while safeguarding and controlling access to content during online delivery through digital rights management, to provide online learning and secure, media-based communications within the OnCallData Community Health Portal.
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast.
› Verified 1 days ago
Nazli Siddiqui, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2506 Fields South Dr Apt 201, Champaign, IL 61822 Phone: 217-607-2522 | |
Tamara Petrovich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 841 Bloomington Rd, Champaign, IL 61820 Phone: 217-356-4827 | |
Carol Pius, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3114 Village Office Pl, Champaign, IL 61822 Phone: 217-378-4807 | |
Aakifa Rahman I, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2610 N Prospect Ave, Champaign, IL 61822 Phone: 217-352-0700 | |
Tramy Vo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 S Neil St, Champaign, IL 61820 Phone: 217-351-1516 Fax: 217-351-1951 | |
Dr. Sebastiano Rosario Mangiamele, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 107 W Green St, Champaign, IL 61820 Phone: 217-355-8123 | |
Jennifer Deschler, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1701 Curtis Rd, Champaign, IL 61822 Phone: 217-365-3274 |